ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Gain Therapeutics Inc

Gain Therapeutics Inc (GANX)

2,43
0,11
(4,74%)
Geschlossen 06 Januar 10:00PM
2,50
0,07
(2,88%)
Nach Börsenschluss: 12:56AM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
2,50
Gebot
2,30
Fragen
6,00
Volumen
360.031
2,2523 Tagesbereich 2,53
0,89 52-Wochen-Bereich 5,33
Marktkapitalisierung
Handelsende
2,32
Handelsbeginn
2,38
Letzte Trade
1
@
2.53
Letzter Handelszeitpunkt
Finanzvolumen
US$ 860.575
VWAP
2,3903
Durchschnittliches Volumen (3 Mio.)
300.309
Ausgegebene Aktien
26.525.068
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,90
Gewinn pro Aktie (EPS)
-0,83
Erlöse
55k
Nettogewinn
-22,11M

Über Gain Therapeutics Inc

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders and oncology. The company has filed four patent applicatio... Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders and oncology. The company has filed four patent applications for novel small molecule drug candidates that are Structurally Targeted Allosteric Regulators (STARs). The company derives revenues from collaboration and licensing agreements. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Gain Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GANX. The last closing price for Gain Therapeutics was US$2,32. Over the last year, Gain Therapeutics shares have traded in a share price range of US$ 0,89 to US$ 5,33.

Gain Therapeutics currently has 26.525.068 shares in issue. The market capitalisation of Gain Therapeutics is US$61,54 million. Gain Therapeutics has a price to earnings ratio (PE ratio) of -2.90.

GANX Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.85551.97568389061.6452.64961.555405542.11394847CS
40.774144.85196129561.72592.64961.52433001.87584167CS
120.55828.73326467561.9423.191.53003092.15501133CS
261.31110.0840336131.193.190.893207891.67303585CS
52-1.23-32.97587131373.735.330.892618542.13680595CS
156-2.95-54.1284403675.456.70.891321902.69604693CS
260-8.72-77.718360071311.2217.930.891247643.84518999CS

GANX - Frequently Asked Questions (FAQ)

What is the current Gain Therapeutics share price?
The current share price of Gain Therapeutics is US$ 2,50
How many Gain Therapeutics shares are in issue?
Gain Therapeutics has 26.525.068 shares in issue
What is the market cap of Gain Therapeutics?
The market capitalisation of Gain Therapeutics is USD 61,54M
What is the 1 year trading range for Gain Therapeutics share price?
Gain Therapeutics has traded in the range of US$ 0,89 to US$ 5,33 during the past year
What is the PE ratio of Gain Therapeutics?
The price to earnings ratio of Gain Therapeutics is -2,9
What is the cash to sales ratio of Gain Therapeutics?
The cash to sales ratio of Gain Therapeutics is 1,15k
What is the reporting currency for Gain Therapeutics?
Gain Therapeutics reports financial results in USD
What is the latest annual turnover for Gain Therapeutics?
The latest annual turnover of Gain Therapeutics is USD 55k
What is the latest annual profit for Gain Therapeutics?
The latest annual profit of Gain Therapeutics is USD -22,11M
What is the registered address of Gain Therapeutics?
The registered address for Gain Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Gain Therapeutics website address?
The website address for Gain Therapeutics is www.gaintherapeutics.com
Which industry sector does Gain Therapeutics operate in?
Gain Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
260,93M
NITON2OFF Inc
US$ 2,6306
(145,85%)
358,28M
CRNCCerence Inc
US$ 19,33
(143,76%)
161,8M
KITTNauticus Robotics Inc
US$ 3,8249
(140,56%)
104,8M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,64M
HWHHWH International Inc
US$ 0,4621
(-28,80%)
7,43M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5,69
(-26,30%)
24,77M
RAINRain Enhancement Technologies Holdco Inc
US$ 5,59
(-23,42%)
161,15k
PTLEPTL Ltd
US$ 9,35
(-23,30%)
1,04M
NXUNXU Inc
US$ 0,725868
(-22,78%)
7,59M
NITON2OFF Inc
US$ 2,6306
(145,85%)
358,28M
TGLTreasure Global Inc
US$ 0,382
(101,58%)
337,5M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,64M
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
260,93M
NVDANVIDIA Corporation
US$ 144,47
(4,45%)
230,01M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock